Department of Neurology, Rothschild Foundation Hospital, Paris.
Department of Interventional Neuroradiology, Rothschild Foundation Hospital, Paris.
Eur J Neurol. 2020 Oct;27(10):1988-1995. doi: 10.1111/ene.14330. Epub 2020 Jun 18.
Malignant middle cerebral artery infarction (MMI) is a severe complication of acute ischaemic stroke (AIS). The aim of our study was to assess whether successful reperfusion after endovascular therapy (EVT) in AIS with clinical and imaging predictors of MMI decreased its occurrence.
Data were collected between January 2014 and July 2018 in a monocentric prospective AIS registry of patients treated with EVT. Patients selected were <65 years old with severe anterior circulation AIS with a National Institutes of Health Stroke Scale score >15, baseline Diffusion-Weighted Imaging-Alberta Stroke Program Early Computed Tomography Score ≤ 6 and baseline diffusion-weighted imaging lesion volume >82 mL within 6 h of symptom onset. Successful reperfusion was defined as a Thrombolysis in Cerebral Ischemia score ≥ 2b. Occurrence of MMI was the primary endpoint.
A total of 66 EVT-treated patients were included in our study. MMI occurred in 27 patients (41%). In unadjusted analysis, successful reperfusion was associated with fewer MMIs (31.8% vs. 65.0%; P = 0.015) and with more favorable outcome at 3 months (50% vs. 20%; P = 0.023). In multivariate analysis, successful reperfusion was associated with an adjusted odds ratio (95% confidence intervals) of 0.35 (0.10-1.12) for MMI and 2.77 (0.84-10.43) for 3-month favorable outcome occurrence.
Early successful reperfusion performed in patients with AIS with clinical and imaging predictors of MMI was associated with decreased MMI occurrence. Reperfusion status might be considered in evaluating the need for craniectomy in patients with early predictors of MMI.
恶性大脑中动脉梗死(MMI)是急性缺血性脑卒中(AIS)的严重并发症。本研究旨在评估 AIS 患者血管内治疗(EVT)后临床和影像学预测因素与 MMI 成功再灌注之间的关系,以降低 MMI 的发生。
本研究为单中心前瞻性 AIS 登记研究,纳入 2014 年 1 月至 2018 年 7 月接受 EVT 治疗的患者。患者年龄<65 岁,有严重前循环 AIS,美国国立卫生研究院卒中量表评分>15 分,基线弥散加权成像-阿尔伯塔卒中计划早期 CT 评分≤6 分,症状发作后 6 小时内弥散加权成像病变体积>82ml。再灌注成功定义为血栓切除术缺血评分≥2b。MMI 的发生是主要终点。
本研究共纳入 66 例接受 EVT 治疗的患者。27 例(41%)患者发生 MMI。在未调整分析中,再灌注成功与较少发生 MMI(31.8%比 65.0%;P=0.015)和 3 个月时更好的预后相关(50%比 20%;P=0.023)。多变量分析显示,再灌注成功与 MMI 的调整比值比(95%可信区间)为 0.35(0.10-1.12),3 个月时良好预后的调整比值比为 2.77(0.84-10.43)。
在有 MMI 临床和影像学预测因素的 AIS 患者中进行早期成功再灌注与降低 MMI 的发生有关。在评估早期有 MMI 预测因素的患者是否需要开颅减压时,可以考虑再灌注状态。